Knights Templar Eye Foundation, Inc. presents $65,000 to UMN researcher.
University of Minnesota Health has launched a new Headache Care program to help Minnesotans gain quick access to specialized headache care and the latest treatments.
The Medical Discovery Team on Addiction is recruiting up to eleven basic scientists and physician-scientists from diverse disciplines, including pharmacology, neuroscience, neurology, psychiatry, and radiology.
Study leads to better understanding of genomic architecture.
The findings may have an immediate impact on clinical practice.
The funding will allow the Medical School at the University of Minnesota to make Minnesota’s health system increasingly “age friendly” by educating and training health professionals in core geriatrics principles that will improve medical care for this growing population.
University of Minnesota Medical School researchers have determined that atrial fibrillation (Afib) is independently associated with changes that occur with aging and dementia.
CentraCare Health and University of Minnesota Physicians have formed a new partnership to meet the growing demand for orthopedic services in Saint Cloud and its surrounding communities.
Cryptococcus neoformans is a fungal pathogen that causes disease in immuno-compromised individuals, particularly those with advanced HIV, organ transplants, or cancer chemotherapy patients.
Device could provide new insight for brain research on concussions, Alzheimer’s and Parkinson’s.